Thor Medical ASA (TRMED.OL)

NOK 2.66

(1.92%)

Market Cap (In NOK)

808.34 Million

Revenue (In NOK)

-

Net Income (In NOK)

-26.56 Million

Avg. Volume

185.18 Thousand

Currency
NOK
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
0.85-4.995
PE
-
EPS
-
Beta Value
0.0
ISIN
NO0010597883
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Jasper Kurth
Employee Count
-
Website
https://www.thormedical.no
Ipo Date
2015-03-23
Details
Thor Medical ASA produces and supplies alpha-particle emitters for cancer therapy in Norway. The company was founded in 2017 and is headquartered in Oslo, Norway.